COMMON STOCK | At March 31, 2016, the Company's authorized capital stock was 150,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share. On that date, the Company had outstanding 42,723,265 shares of common stock, and no shares of preferred stock. 2016 Transactions · 212,500 shares of common stock for prior services which had previously been recorded as accrued liability for $28,199 or $0.13 per share. 2015 Transactions · 31,659 shares of common stock for services valued at $0.23 per share. · 12,500 shares of common stock for prior services which had previously been recorded as accrued liability for $2,692 or $0.24 per share. · 200,000 shares of common stock for prior services which had previously been recorded as accrued liability for $65,211 or $0.18 per share. Common Stock Repurchase Program On October 29, 2014, the Companys board of directors approved a share repurchase program that enables the Company to purchase shares of common stock. Under this program, 3PEA is authorized, but not obligated to repurchase, through open market purchases or privately negotiated transactions up to two million seven hundred thousand (2,700,000) of its shares of common stock, depending on market conditions, share price and other factors, subject to relevant rules and regulations under U.S. securities law. The Company acquired 2,442,000 through this program. The share repurchase program expired on October 29, 2015. Stock and Warrant Grants: In March 2015 the Company granted 200,000 shares of common stock along with 200,000 warrants to a consultant. The shares were valued at $30,600 or $0.16 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The warrants were valued at $34,611, using the Black-Scholes options pricing model under the following assumptions: stock price at issuance of $0.18 per share; exercise price of $0.25, 3 year life; discount rate of 2.00%; and volatility rate of 245%. The 200,000 shares and 200,000 warrants granted have a vesting period of six months of which one month, and were fully vested as of March 31, 2016. The approximate value vested for the three months ended March 31, 2015 was $4,600, for which a payable has been recorded for the same vested amount. As of March 31, 2015, 200,000 shares or 200,000 warrants granted have been issued. In August 2014 the Company granted 150,000 shares of common stock to a consultant with a total value of $25,500 or $0.17 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The 150,000 shares granted have a vesting period of three years of which twenty months had vested as of March 31, 2016. The approximate value vested for the three months ended March 31, 2016 and 2015 was $2,100 and $2,100, respectively As of March 31, 2016, 100,000 shares granted have been issued. In September 2014 the Company granted 150,000 shares of common stock along with 150,000 Class A warrants and 150,000 Class B warrants to an advisory board member. The shares were valued at $19,250 or $0.13 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity. The warrants were valued at $42,761, using the Black-Scholes options pricing model under the following assumptions: stock price at issuance of $0.15 per share; exercise price of $0.25 for the Class A warrants and $0.50 for the Class B warrants; 3 year life; discount rate of 2.00%; and volatility rate of 245%. The 150,000 shares and 300,000 warrants granted vest over a 3 year period, at 50,000 shares and 100,000 warrants per year of which nineteen months had vested as of March 31, 2016. The approximate value vested for the three months ended March 31, 2016 and 2015 was $5,100 and $5,100, respectively. As of March 31, 2016, none of the 150,000 shares or 300,000 warrants granted has been issued. In September 2014 the Company granted 200,000 shares of common stock along with 200,000 warrants to a consultant. The shares were valued at $30,600 or $0.16 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The warrants were valued at $34,611, using the Black-Scholes options pricing model under the following assumptions: stock price at issuance of $0.18 per share; exercise price of $0.25; 3 year life; discount rate of 2.00%; and volatility rate of 245%. The 150,000 shares and 200,000 warrants granted had a vesting period of six months and were fully vested as March 31, 2016. In April 2016, the company had issued the 200,000 shares and warrant for 200,000 shares of common stock. In October 2014 the Company granted 150,000 shares of common stock to an advisory board member with a total value of $32,400 or $0.21 per share (including a 10% discount of fair market value due to these shares being restricted and lacking market liquidity). The 150,000 shares granted will vest over a 3 year period, at 50,000 shares per year of which eighteen months had vested as of March 31, 2016. The approximate value vested for the three months ended March 31, 2016 and 2015 was $2,700 and $2,200, respectively. As of March 31, 2016, 62,500 of the shares previously vested have been issued and the remaining 87,500 shares granted have not been issued. In November 2014, the Company issued a warrant for 100,000 shares of common stock as part of a debt settlement, whereby the noteholder returned 2,442,000 shares of the Companys common stock in connection with the Companys satisfaction of all principal and interest due on the note. The warrant has an exercise price of $0.50 and life of three years. In October 2013, the Company granted 300,000 shares of common stock to an employee of the Company with a total value of $38,250 or $0.15 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The 300,000 shares granted have a vesting period of three years. The approximate value vested for the three months ended March 31, 2016 and 2015 was $3,200 and $3,200, respectively. As of March 31, 2016, 200,000 shares granted have been issued and the remaining 100,000 shares granted have not been issued. In August 2012, the Company granted a total of 5,000,000 shares of common stock to various officers and directors of the Company with a total value of $680,000 or $0.14 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The 5,000,000 shares granted had a vesting period of five years of which all have been fully vested as of December 31, 2014. The approximate value vested for the year ended December 31, 2014 was $680,000 for which a payable has been recorded for the same vested amount as of December 31, 2014. As of March 31, 2015, all of the 5,000,000 shares granted had been issued. |